ArticleNeuroImage. Clinical2026
Macro-Micro structural integration for characterizing severity-related structural alterations in mild cognitive impairment.
Article in NeuroImage. Clinical, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Mild cognitive impairment (MCI) is a clinically heterogeneous condition characterized by substantial variation in structural abnormalities and cognitive impairment. However, existing neuroimaging-based approaches are limited by insufficient modeling of coordinated gray-white matter alterations and vulnerability to site effects in multi-center data. Here, we propose a Macro-Micro Structural Integration (MMSI) framework for characterizing structural-deviation heterogeneity and identifying imaging-derived MCI subgroups. The framework integrates gray-matter morphological features derived from structural magnetic resonance imaging and white-matter microstructural features derived from diffusion MRI. A Dual-Condition Variational Autoencoder was developed to separate biological variation from site-related effects and learn a site-robust normative representation using cognitively normal participants. Tract-specific MMSI scores were subsequently derived to quantify each participant's structural deviation from the normative reference. In a multi-center clinical cohort (N = 860), Gaussian mixture modeling of the tract-wise MMSI profiles identified lower- and higher-deviation MCI subgroups that exhibited significant differences in global cognition, delayed memory, and word recognition. Comparisons with conventional imaging biomarkers, machine-learning classifiers, and statistical harmonization methods further supported the value of the proposed framework. Evaluation in the Alzheimer's Disease Neuroimaging Initiative cohort demonstrated a concordance accuracy of 0.769 between the imaging-derived groups and the clinically predefined early- and late-MCI categories, exceeding the gray matter-only and white matter-only models by 7.7 and 12.3 percentage points, respectively. Transcriptomic association analysis identified KRT77 and CACNA1B as significantly associated with tract-specific MMSI scores after false discovery rate correction. Functional enrichment of the PLS-derived MMSI-associated gene set implicated biological processes related to neural signal transduction, learning and memory, calcium signaling, and immune responses. Together, these findings indicate that the MMSI framework provides a site-robust and interpretable approach for characterizing cross-sectional structural-deviation heterogeneity in MCI and offers preliminary biological support for the identified imaging patterns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.